Scarica l'app Stockscreener
1.16
5.91%
0.06
Precedente Chiudi:
$1.10
Aprire:
$1.1
Volume 24 ore:
228.90K
Relative Volume:
0.77
Capitalizzazione di mercato:
$54.66M
Reddito:
$928.00K
Utile/perdita netta:
$-11.11M
Rapporto P/E:
-3.263
EPS:
-0.3555
Flusso di cassa netto:
$-10.40M
1 W Prestazione:
+15.35%
1M Prestazione:
+34.68%
6M Prestazione:
-1.27%
1 anno Prestazione:
+14.22%
Intervallo 1D:
$1.10
$1.17
Intervallo di 1 settimana:
$0.9701
$1.19
Portata 52W:
$0.7006
$1.45
Renovorx Inc Stock (RNXT) Company Profile
Nome
Renovorx Inc
Settore
Industria
Telefono
408-800-2649
Indirizzo
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Compare RNXT vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.1559 | 52.02M | 928.00K | -11.11M | -10.40M | -0.3555 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Renovorx Inc Borsa (RNXT) Ultime notizie
RenovoRx surpasses 100 patients in Phase III pancreatic trial By Investing.com - Investing.com India
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment - The Manila Times
RenovoRx pancreatic cancer trial passes 100 patients, 2027 data next - Stock Titan
RenovoRx CFO voll acquires shares and warrants in RNXT By Investing.com - Investing.com Australia
Laurence Marton buys RenovoRx stock and warrants for $10,000 By Investing.com - Investing.com South Africa
Shaun Bagai, CEO of Renovorx, buys $0 of RNXT stock - Investing.com
Laurence Marton buys RenovoRx stock and warrants for $10,000 - Investing.com
RenovoRx (RNXT) CEO’s family trust buys shares and new warrants - Stock Titan
RenovoRx (RNXT) director adds $10K via rollover IRA private deal - Stock Titan
The most innovative medical device companies of 2026 - Fast Company
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement - Investing News Network
RenovoRx Secures $10 Million Oversubscribed Private Placement to Accelerate RenovoCath Commercialization and Advance Phase III Pancreatic Cancer Trial - Minichart
Trend Recap: Can RenovoRx Inc expand its profit margins2026 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
RenovoRx Raises $10 Million in Oversubscribed Private Placement - TipRanks
RenovoRx Raises ~$10 Million in Private Placement; Sells Stock and Warrants at $0.938 Per Share - TradingView
RenovoRx (Nasdaq: RNXT) nets $10M private placement with milestone warrants - Stock Titan
RenovoRx (RNXT) Expected to Announce Quarterly Earnings on Monday - Defense World
Panic Selling: How does RenovoRx Inc perform in inflationary periods2026 Geopolitical Influence & Entry and Exit Point Strategies - baoquankhu1.vn
Downgrade Watch: Can RenovoRx Inc deliver alphaWeekly Trade Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET - Investing News Network
Draganfly to Host Shareholder Update Call on March 24, 2026 - weeklyvoice.com
RenovoRx March 30 call to cover 2025 results, Phase III trial timing - Stock Titan
RenovoRx, Inc. announced that it has received $10 million in funding from Transcend Partners LLC, Aigh Capital Management, LLC, Bleichroeder LP, Pathfinder Asset Management Limited - marketscreener.com
Aug Wrap: Can KLRS outperform under higher oil prices2026 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Risk Off: Will cbdMD Inc outperform its industry peers2026 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn
RenovoRx raises $10M in oversubscribed private placement By Investing.com - Investing.com Australia
Support Test: Is RenovoRx Inc exposed to political riskEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
RenovoRx Announces $10 Million at Market Private Placement - Investing News Network
RenovoRx prices 10.6M shares at 93.8c in private placement - TipRanks
RenovoRx, Inc. announced that it expects to receive $10 million in funding - marketscreener.com
RenovoRx announces $10 million private placement - MSN
RenovoRx raises $10M in oversubscribed private placement - Investing.com
RenovoRx announces $10 million at market Private Placement - marketscreener.com
Renovorx Announces $10 Million At Market Private Placement - TradingView
$10M investor bet on RenovoRx cancer device and trial push - Stock Titan
Aug Fed Impact: Is RenovoRx Inc a defensive stock2026 Market Mood & Safe Capital Growth Tips - baoquankhu1.vn
RNXT Should I Buy - Intellectia AI
Gains Recap: What hedge funds are buying Arko CorpRate Cut & AI Forecast Swing Trade Picks - baoquankhu1.vn
Returns Recap: Can RenovoRx Inc expand its profit margins2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
What dividend safety score for RenovoRx Inc. stockEarnings Recap Report & Real-Time Volume Surge Alerts - Naître et grandir
Market Review: How much upside does RenovoRx Inc have2025 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
Insider Buy: Is RenovoRx Inc stock a value trapJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Macro: What chart patterns are forming on RenovoRx IncRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Block Trades: Will RenovoRx Inc benefit from rate cuts2025 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Guidance Update: Is RenovoRx Inc stock overvalued or fairly pricedJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
RenovoRx Advancing RenovoCath Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - marketscreener.com
US Market Recap: Whats the outlook for RenovoRx Incs sectorM&A Rumor & AI Enhanced Trading Alerts - baoquankhu1.vn
RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Down 20.6% in February - Defense World
RenovoRx advances RenovoCath adoption at U.S. cancer centers - Yahoo Finance
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - Investing News Network
After 700 cancer procedures, RenovoCath gets new doctor-led commercial push - Stock Titan
Renovorx Inc Azioni (RNXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):